Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCR100 in Knee Osteoarthritis
NCT06741098Phase 2Not yet recruiting
- Sponsor
- Nuwacell Biotechnologies
- Start
- Feb 2025
- Primary completion
- Nov 2026
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of NCR100 in knee osteoarthritis (OA), sponsored by Nuwacell Biotechnologies. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
NCR100
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06741098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06741098.